South Africa rolls out new single dose AIDS drug

April 8, 2013

South Africa's health minister on Monday launched a new single dose anti-AIDs drug which will simplify the world's biggest HIV treatment regime to just one life-saving pill a day.

The three-in-one combination anti-retroviral (ARV) was secured at a record-low price and will cost the state 89 rand a month ($10, eight euros) per patient.

"Before 2010, we were buying the most expensive ARVs in the world. Now we are a country where the ARVs are the cheapest in the world," said Aaron Motsoaledi.

"It means we can increase the number of people on treatment," he added during a visit to the township of Ga-Rankuwa, about 35 kilometres (22 miles) northwest of the capital Pretoria.

After years of refusing to roll out ARVs, South Africa now has 1.9 million people on treatment among its 5.6 million -positive population, which is the world's largest.

The new pill will be introduced this month to positive and , people co-infected with TB, and to new ARV patients.

Patients already on treatment will be assessed by doctors to start switching later this year.

"You're just going to take it once, and it's just going to be less pill burden," said patient Andrew Mosani.

"People are tired (of) taking many drugs on a day to day basis."

The pill also had fewer side effects and was easy to swallow, he added.

The South African National AIDS Council welcomed the treatment shift, saying it hoped it would encourage patients to stay on treatment.

"This is simplifying the way patients have become used to taking ARV treatment," said the council's CEO Fareed Abdullah.

"We have come a very long way since the advent of anti-retrovirals. At one point, patients used to take up to 16 pills a day," he added.

South Africa once refused to roll out ARVs under former president Thabo Mbeki but now has the largest anti-retroviral (ARV) programme in the world.

The scaling up of has seen the number of pregnant women passing on HIV to their babies brought down to less than three percent.

Life expectancy has also shot up by six years to 60 over the past few years.

Explore further: S.Africa seals record deal for low-cost ARVs: minister

Related Stories

S.Africa seals record deal for low-cost ARVs: minister

November 29, 2012
South Africa, home to the world's largest population of people living with HIV, said Thursday it had secured a deal to buy a key anti-retroviral (ARV) drug at the lowest price ever.

S.Africa marks AIDS day with record ribbon

December 2, 2012
South Africa, home to the world's largest HIV caseload, on Saturday unveiled a 1.5 kilometre AIDS ribbon in Johannesburg, with activists and officials pledging to curb the epidemic.

South Africa unveils plan to halve HIV infections

December 1, 2011
President Jacob Zuma on Thursday unveiled a plan to halve the number of HIV infections over the next five years, cementing South Africa's turnaround from years of deadly denialism.

South Africa reports new success in saving newborns from HIV

July 19, 2012
About 117,000 babies were saved from HIV infection last year under South Africa's scheme to prevent mothers from passing on the disease during childbirth, health official said Thursday.

Sanofi teams up with India to make cheap ARVs in S.Africa

March 30, 2012
French pharmaceutical giant Sanofi has signed a partnership with India's Hetero to manufacture cheap anti-HIV drugs in South Africa, the company said on Friday.

Life expectancy shoots up to 60 in SAfrica: study

October 18, 2012
Life expectancy in AIDS-hit South Africa has shot up by six years to 60 over the past few years, thanks to life prolonging anti-retroviral (ARVs) treatment, a demographer said Thursday.

Recommended for you

Paris spotlight on latest in AIDS science

July 21, 2017
Some 6,000 HIV experts gather in Paris from Sunday to report advances in AIDS science as fading hopes of finding a cure push research into new fields.

Scientists elicit broadly neutralizing antibodies to HIV in calves

July 20, 2017
Scientists supported by the National Institutes of Health have achieved a significant step forward, eliciting broadly neutralizing antibodies (bNAbs) to HIV by immunizing calves. The findings offer insights for HIV vaccine ...

Heart toxin reveals new insights into HIV-1 integration in T cell genome

July 20, 2017
Human immunodeficiency virus (HIV)-1 may have evolved to integrate its genetic material into certain immune-cell-activating genes in humans, according to new research published in PLOS Pathogens.

Scientists capture first high-resolution image of key HIV protein transitional state

July 13, 2017
A new, three-dimensional snapshot of HIV demonstrates the radical structural transformations that enable the virus to recognize and infect host cells, according to a new study led by scientists at The Scripps Research Institute ...

Barrier to autoimmune disease may open door to HIV, study suggests

July 11, 2017
Researchers from the University of Colorado School of Medicine have discovered that a process that protects the body from autoimmune disease also prevents the immune system from generating antibodies that can neutralize the ...

Team tests best delivery mode for potential HIV vaccine

June 20, 2017
For decades, HIV has successfully evaded all efforts to create an effective vaccine but researchers at The Scripps Research Institute (TSRI) and the La Jolla Institute for Allergy and Immunology (LJI) are steadily inching ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.